Aquestive Therapeutics News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Aquestive Therapeutics Inc AQST NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.17 4.03% 4.39 20:00:00
Open Price Low Price High Price Close Price Prev Close
4.49 3.90 4.58 4.41 4.22
more quote information »

Recent News

Date Time Source Heading
3/05/202107:00GLOBEAquestive Therapeutics to Host Investor & Analyst Virtual..
2/25/202107:59SEEKAquestive receives FDA feedback; to resubmit marketing..
2/25/202107:31EDGARCurrent Report Filing (8-k)
2/25/202107:30GLOBEAquestive Therapeutics Reaffirms Near-Term NDA Resubmission..
2/22/202116:44EDGARInitial Statement of Beneficial Ownership (3)
2/17/202107:30GLOBEAquestive Therapeutics to Announce Fourth Quarter and Year..
2/09/202107:35EDGARCurrent Report Filing (8-k)
1/28/202107:30GLOBEAquestive Therapeutics Appoints Mark Lepore, MD, as Chief..
1/21/202116:34EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
1/21/202108:41EDGARCurrent Report Filing (8-k)
1/21/202108:30PRNUSMitsubishi Tanabe Pharma America and Aquestive Therapeutics..
1/20/202106:05EDGARNotice of Effectiveness (effect)
1/08/202116:46EDGARSecurities Registration Statement (simplified Form) (s-3)
1/08/202107:01EDGARCurrent Report Filing (8-k)
1/07/202107:36EDGARCurrent Report Filing (8-k)
1/07/202107:30GLOBEAquestive Therapeutics Provides Business Update
1/04/202116:06EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202107:30GLOBEAquestive Therapeutics to Present at Two Upcoming Investor..
12/17/202007:00EDGARCurrent Report Filing (8-k)
12/16/202008:00GLOBEAquestive Therapeutics Announces Departure of Chief..
12/01/202006:01EDGARAmended Statement of Ownership (sc 13g/a)
11/25/202009:15GLOBEAquestive Therapeutics to Present at Piper Sandler 32nd..
11/23/202007:15EDGARCurrent Report Filing (8-k)
11/23/202007:00GLOBEAquestive Therapeutics Receives First Milestone Payment from..
11/18/202016:01GLOBEAquestive Therapeutics Completes FDA Type A Meeting on..
11/04/202016:36EDGARCurrent Report Filing (8-k)
11/04/202016:30GLOBEAquestive Therapeutics Reports Third Quarter 2020 Financial..
11/03/202007:03EDGARCurrent Report Filing (8-k)
11/03/202007:00GLOBEAquestive Therapeutics Signs Royalty Monetization Agreement..
10/14/202007:30GLOBEAquestive Therapeutics to Announce Third Quarter Financial..
9/25/202017:38GLOBEAquestive Therapeutics Receives Complete Response Letter..
9/25/202017:28EDGARCurrent Report Filing (8-k)
8/20/202007:30GLOBEAquestive Therapeutics Initiates Phase 1 Pharmacokinetic..
8/19/202008:56EDGARStatement of Changes in Beneficial Ownership (4)
8/10/202007:37EDGARCurrent Report Filing (8-k)
8/10/202007:30GLOBEAquestive Therapeutics Receives FDA Fast Track Designation..
8/04/202016:50EDGARQuarterly Report (10-q)
8/04/202016:27EDGARCurrent Report Filing (8-k)
8/04/202016:01GLOBEAquestive Therapeutics Reports Second Quarter 2020 Financial..
7/28/202016:15GLOBEAquestive Therapeutics to Present at 2020 Wedbush PacGrow..
7/15/202007:57GLOBEAquestive Therapeutics to Announce Second Quarter Financial..
7/02/202016:26EDGARStatement of Changes in Beneficial Ownership (4)
7/02/202016:26EDGARStatement of Changes in Beneficial Ownership (4)
7/02/202014:44EDGARCurrent Report Filing (8-k)
6/29/202008:29EDGARCurrent Report Filing (8-k)
6/29/202007:00GLOBEAquestive Therapeutics Files IND for Pharmacokinetic..
6/18/202017:13EDGARStatement of Changes in Beneficial Ownership (4)
6/18/202016:06EDGARStatement of Changes in Beneficial Ownership (4)
6/18/202016:06EDGARStatement of Changes in Beneficial Ownership (4)
6/18/202016:06EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »

Your Recent History
Aquestive ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.